Australia · Delayed Price · Currency is AUD MedAdvisor Statistics
Total Valuation
MedAdvisor has a market cap or net worth of AUD 27.51 million. The enterprise value is 34.60 million.
| Market Cap | 27.51M |
| Enterprise Value | 34.60M |
Important Dates
The last earnings date was Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedAdvisor has 625.25 million shares outstanding. The number of shares has increased by 4.71% in one year.
| Current Share Class | 625.25M |
| Shares Outstanding | 625.25M |
| Shares Change (YoY) | +4.71% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.68% |
| Owned by Institutions (%) | 36.57% |
| Float | 393.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 133.33 |
| PS Ratio | 0.44 |
| PB Ratio | -17.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.57 |
| EV / Sales | 0.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73
| Current Ratio | 1.73 |
| Quick Ratio | 0.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.54 |
Financial Efficiency
Return on equity (ROE) is -253.44% and return on invested capital (ROIC) is -20.41%.
| Return on Equity (ROE) | -253.44% |
| Return on Assets (ROA) | -11.77% |
| Return on Invested Capital (ROIC) | -20.41% |
| Return on Capital Employed (ROCE) | -77.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.91 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MedAdvisor has paid 5,951 in taxes.
| Income Tax | 5,951 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.25% in the last 52 weeks. The beta is 0.84, so MedAdvisor's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -87.25% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 33.73 |
| Average Volume (20 Days) | 614,684 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedAdvisor had revenue of AUD 62.99 million and -60.21 million in losses. Loss per share was -0.10.
| Revenue | 62.99M |
| Gross Profit | 3.97M |
| Operating Income | -13.06M |
| Pretax Income | -63.31M |
| Net Income | -60.21M |
| EBITDA | -11.93M |
| EBIT | -13.06M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 10.30 million in cash and 17.40 million in debt, giving a net cash position of -7.09 million or -0.01 per share.
| Cash & Cash Equivalents | 10.30M |
| Total Debt | 17.40M |
| Net Cash | -7.09M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -1.62M |
| Book Value Per Share | -0.00 |
| Working Capital | 16.60M |
Cash Flow
| Operating Cash Flow | -14.37M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 6.31%, with operating and profit margins of -20.73% and -95.58%.
| Gross Margin | 6.31% |
| Operating Margin | -20.73% |
| Pretax Margin | -100.50% |
| Profit Margin | -95.58% |
| EBITDA Margin | -18.94% |
| EBIT Margin | -20.73% |
| FCF Margin | n/a |
Dividends & Yields
MedAdvisor does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.71% |
| Shareholder Yield | n/a |
| Earnings Yield | -218.85% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 20, 2019. It was a reverse split with a ratio of 0.1428571429.
| Last Split Date | Nov 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1428571429 |
Scores
MedAdvisor has an Altman Z-Score of -1.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.51 |
| Piotroski F-Score | 2 |